In the wake of the increase in Current Liabilities in the first quarter 2025, Quick Ratio fell to 0.25 a new company low.

Within Laboratory Analytical Instruments industry 7 other companies have achieved higher Quick Ratio than Akoya Biosciences Inc in first quarter 2025. While Quick Ratio total ranking in the first quarter 2025 has deteriorated compared to the prior quarter from 1479 to 1902.

Explain Quick Ratio?
How much Cash & cash equivalents AKYA�s has?
What are AKYA�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKYA Quick Ratio	(Mar 31 2025) Q1	(Dec 31 2024) Q4	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1
Y / Y Current Liabilities Change	225.62 %	37.13 %	-21.2 %	-12.44 %	-0.09 %
Y / Y Cash & cash equivalent Change	-55.27 %	-57.85 %	-54.33 %	-51.54 %	2.2 %
Quick Ratio MRQ	0.25	1.19	1.28	1.38	1.86
AKYA's Total Ranking	# 1902	# 1479	# 1389	# 973	# 819
Seq. Current Liabilities Change	267.08 %	5.18 %	-14.49 %	-1.37 %	54.59 %
Seq. Cash & cash equivalent Change	-21.39 %	-2.38 %	-20.63 %	-26.55 %	-25.92 %

Quick Ratio first quarter 2025 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 8
Healthcare Sector	# 534
Overall Market	# 1902

Quick Ratio Statistics
High	Average	Low
7.46	2.62	0.25
(Jun 30 2021)		(Mar 31 2025)

Financial Statements
Akoya Biosciences Inc 's Current Liabilities	$ 108 Millions	Visit AKYA's Balance sheet
Akoya Biosciences Inc 's Cash & cash equivalent	$ 28 Millions	Visit AKYA's Balance sheet
Source of AKYA's Sales		Visit AKYA's Sales by Geography

Cumulative Akoya Biosciences Inc 's Quick Ratio

AKYA's Quick Ratio for the trailling 12 Months

AKYA Quick Ratio	(Mar 31 2025) 12 Months	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	55.4 %	-3.32 %	-16.25 %	-8.22 %	-2.11 %
Y / Y Cash & cash equivalent TTM Growth	-54.61 %	-43.63 %	-27.94 %	-15.16 %	1.88 %
Quick Ratio TTM	0.72	1.44	1.96	2.18	2.48
Total Ranking TTM	# 3407	# 2623	# 3311	# 3281	# 2592
Seq. Current Liabilities TTM Growth	60.7 %	6.91 %	-6.13 %	-3.65 %	-0.02 %
Seq. Cash & cash equivalent TTM Growth	-19.15 %	-21.29 %	-15.9 %	-15.19 %	0.42 %

Quick ratio ranking by company, industry and sector >> Back to AKYA Financial Strength Comparisons >> Go to Compare AKYA Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q1 2025 to $108.08 millions, cumulative Quick Ratio decreased to 0.72 below the Akoya Biosciences Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 22 other companies have achieved higher Quick Ratio than Akoya Biosciences Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 2623 to 3407.

Explain Quick Ratio?
How much Cash & cash equivalents AKYA�s has?
What are AKYA�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 23
Healthcare Sector	# 915
Within the Market	# 3407

trailing twelve months Quick Ratio Statistics
High	Average	Low
4.88	2.58	0.72
(Mar 31 2022)		(Mar 31 2025)

Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Laboratory Analytical Instruments Industry	Quick Ratio	Mar 31 2025 MRQ Cash & cash equivalent	Mar 31 2025 MRQ Current Liabilities
Waters Corporation	0.42	$ 382.872 Millions	$ 912.094 Millions
Kewaunee Scientific Corporation	0.32	$ 17.164 Millions	$ 53.712 Millions
Precipio inc	0.27	$ 1.017 Millions	$ 3.712 Millions
Akoya Biosciences Inc	0.25	$ 27.544 Millions	$ 108.082 Millions
Bruker Corporation	0.21	$ 184.200 Millions	$ 874.300 Millions
Illumina Inc	0.17	$ 124.000 Millions	$ 723.000 Millions
Avantor Inc	0.16	$ 315.700 Millions	$ 2,034.400 Millions
Harvard Bioscience Inc	0.11	$ 5.546 Millions	$ 52.176 Millions
BIOFORCE NANOSCIENCES HOLDINGS, INC.	0.06	$ 0.014 Millions	$ 0.233 Millions

Date modified: 2026-09-08T15:11:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.